» Articles » PMID: 3928029

Genetic Heterogeneity in Acute Intermittent Porphyria: Characterisation and Frequency of Porphobilinogen Deaminase Mutations in Finland

Overview
Specialty General Medicine
Date 1985 Aug 24
PMID 3928029
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The occurrence of different porphobilinogen deaminase mutant types in 68 patients with acute intermittent porphyria from 33 unrelated families in Finland was studied with biochemical and immunological techniques. In this fairly homogenous population four different porphobilinogen deaminase mutant types were identified and their frequencies determined. Most (about 80%) of the mutations were cross reacting immunological material (CRIM) negative, including a large kindred with normal erythrocyte porphobilinogen deaminase activities. The remainder of the families had CRIM positive mutations, including an unusual type (type 2) that had an immunoreactive, non-catalytic porphobilinogen deaminase level considerably greater than the maximal theoretical ratio of CRIM to activity of 2.0 for a single mutant allele. Correlations of the amount of residual porphobilinogen deaminase activity and the occurrence of acute clinical manifestations in each mutant type suggested that CRIM positive type 2 patients may have fewer acute symptoms.

Citing Articles

Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.

Balogun O, Nejak-Bowen K Semin Liver Dis. 2024; 44(2):209-225.

PMID: 38772406 PMC: 11268267. DOI: 10.1055/s-0044-1787076.


Characterization of porphobilinogen deaminase mutants reveals that arginine-173 is crucial for polypyrrole elongation mechanism.

Bustad H, Kallio J, Laitaoja M, Toska K, Kursula I, Martinez A iScience. 2021; 24(3):102152.

PMID: 33665570 PMC: 7907807. DOI: 10.1016/j.isci.2021.102152.


Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review.

Calanzani N, Druce P, Snudden C, Milley K, Boscott R, Behiyat D Adv Ther. 2020; 38(2):793-834.

PMID: 33306189 PMC: 7889689. DOI: 10.1007/s12325-020-01571-z.


Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria.

Chen B, Solis-Villa C, Erwin A, Balwani M, Nazarenko I, Phillips J J Inherit Metab Dis. 2019; 42(1):186-194.

PMID: 30740734 PMC: 6162174. DOI: 10.1002/jimd.12040.


Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria.

Puy H, Deybach J, Lamoril J, Robreau A, Da Silva V, Gouya L Am J Hum Genet. 1997; 60(6):1373-83.

PMID: 9199558 PMC: 1716106. DOI: 10.1086/515455.


References
1.
STRAND L, Felsher B, Redeker A, MARVER H . Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci U S A. 1970; 67(3):1315-20. PMC: 283354. DOI: 10.1073/pnas.67.3.1315. View

2.
Miyagi K, Cardinal R, Bossenmaier I, Watson C . The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med. 1971; 78(5):683-95. View

3.
Meyer U, STRAND L, Doss M, Rees A, MARVER H . Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism. N Engl J Med. 1972; 286(24):1277-82. DOI: 10.1056/NEJM197206152862401. View

4.
NEVANLINNA H . The Finnish population structure. A genetic and genealogical study. Hereditas. 1972; 71(2):195-236. DOI: 10.1111/j.1601-5223.1972.tb01021.x. View

5.
Mustajoki P, KOSKELO P . Hereditary hepatic porphyrias in Finland. Acta Med Scand. 1976; 200(3):171-8. DOI: 10.1111/j.0954-6820.1976.tb08216.x. View